Integrin αvβ3, traditionally recognized for its role in signal transduction and extracellular matrix interactions, has been identified as a membrane-associated estrogen receptor in both ER-α-positive and ER-α-negative breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.